Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The EBITDA margin is -10097.04%.
Reported quarterly EBITDA margin; no daily interpolation. Q3 FY2025 (2025-09-30): -2493.79%.
EBITDA MARGIN
-10097.04%
EBITDA MARGIN AVG TTM
N/A
EBITDA MARGIN AVG 3Y
N/A
EBITDA MARGIN AVG 5Y
N/A
EBITDA MARGIN AVG 10Y
N/A
EBITDA MARGIN AVG 15Y
-3059.05%
EBITDA MARGIN AVG 20Y
-1597.58%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-230.07%
CURRENT VS 20Y AVG
-532.02%
Market Cap
$30.10M
EBITDA Margin
-2671.72%
TTM Avg
-3785.12%
3Y Avg
-14400.08%
5Y Avg
-14400.08%
Market Cap
$30.66M
EBITDA Margin
-5.74%
TTM Avg
-12.14%
3Y Avg
-35.62%
5Y Avg
-63.06%
Market Cap
$30.63M
EBITDA Margin
-76.51%
TTM Avg
-510.64%
3Y Avg
-659.38%
5Y Avg
-619.37%
Market Cap
$30.85M
EBITDA Margin
-108.41%
TTM Avg
-31.49%
3Y Avg
5.24%
5Y Avg
21.14%
Market Cap
$29.63M
EBITDA Margin
-17954.61%
TTM Avg
-17954.61%
3Y Avg
-17954.61%
5Y Avg
-17954.61%
Market Cap
$29.60M
EBITDA Margin
-2299.40%
TTM Avg
-2138.43%
3Y Avg
-3018.63%
5Y Avg
-2749.35%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CervoMed Inc. (CRVO) | $30.18M | -10097.04% | N/A | N/A | N/A |
| MIRA Pharmaceuticals, Inc. (MIRA)vs › | $30.18M | N/A | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $30.10M | -2671.72% | -3785.12% | -14400.08% | -14400.08% |
| MDxHealth S.A. (MDXH)vs › | $30.66M | -5.74% | -12.14% | -35.62% | -63.06% |
| SCYNEXIS, Inc. (SCYX)vs › | $30.63M | -76.51% | -510.64% | -659.38% | -619.37% |
| Baird Medical Investment Holdings Limited (BDMD)vs › | $30.85M | -108.41% | -31.49% | 5.24% | 21.14% |
| GridAI Technologies Corp. (GRDX)vs › | $29.63M | -17954.61% | -17954.61% | -17954.61% | -17954.61% |
| Context Therapeutics Inc. (CNTX)vs › | $29.60M | N/A | N/A | N/A | N/A |
| Quantum Cyber N.V. (QUCY)vs › | $29.60M | -2299.40% | -2138.43% | -3018.63% | -2749.35% |
| Nortech Systems Incorporated (NSYS)vs › | $31.44M | 2.14% | 1.67% | 3.35% | 2.87% |
Gross Margin
0.0%
EBITDA Margin
-10097.0%
Operating Margin
0.0%
Net Margin
-9408.8%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2025-09-30 | -2493.79% |
| 2012-09-30 | -2383.35% |
| 2012-06-30 | -3394.63% |
| 2012-03-31 | -1468.03% |
| 2011-12-31 | -2649.84% |
| 2011-09-30 | -1645.95% |
| 2010-12-31 | -7377.80% |
| 2008-06-30 | -20841.05% |
| 2008-03-31 | -630.39% |
| 2007-09-30 | -78.20% |
| 2007-06-30 | -510.35% |
| 2007-03-31 | -721.27% |
| 1999-06-30 | -6.50% |
| 1998-12-31 | -1.47% |
| 1998-09-30 | 4.88% |
